Melatonine Bluefish

Melatonin, the active ingredient in Melatonine Bluefish, is a Melatonin receptor agonist presented as an unknown/unknown for oral use. It helps regulate the circadian rhythm and is used to manage insomnia, jet lag and other sleep disorders in adults.

GNH USA supplies Melatonine Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to support normal sleep physiology. - Insomnia: facilitates sleep onset and improves sleep continuity. - Jet lag: assists rapid adjustment of the internal clock after trans‑meridian travel. - General sleep disorders: promotes regular sleep‑wake cycles and reduces nighttime awakenings.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild stomach discomfort - Vivid dreams or altered dream patterns - Mild fatigue

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling - Severe dizziness or fainting - Mood changes including depression or anxiety - Abnormal heart rhythm or palpitations - Hallucinations or confusion - Severe skin reactions like Stevens‑Johnson syndrome

When using melatonin, consider the following safety measures. - Consult healthcare provider: before use in children, the elderly, or patients with liver disease. - Avoid driving or operating machinery: possible residual drowsiness. - Do not combine with alcohol: may increase sedation. - Discontinue if allergic reaction occurs: seek medical attention promptly. - Store at room temperature: keep in the original container, protect from moisture and light.

Melatonin can interact with several medication classes.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: may reduce melatonin efficacy. - CYP1A2 inhibitors (e.g., fluvoxamine): can raise melatonin plasma levels.

Moderate Interactions (Monitor Closely): - Sedatives or hypnotics: additive central nervous system depression. - Antidepressants (SSRIs): may alter sleep architecture. - Caffeine-containing products: may counteract melatonin’s sleep‑promoting effect.